Intercept Pharmaceuticals

Intercept Pharmaceuticals
10 Hudson Yards, 37th Floor
New York, NY 10001

About

We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.

In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.

Our corporate headquarters is located in New York, and we have additional offices in San Diego, London and Perugia.

Company profile type: 
Employer
Company size: 
251-1000 employees

Pages

Company Locations

Address information

10 Hudson Yards, 37th Floor
New York, NY 10001